501 related articles for article (PubMed ID: 24933005)
21. New Insights into Chikungunya Virus Infection and Pathogenesis.
Kril V; Aïqui-Reboul-Paviet O; Briant L; Amara A
Annu Rev Virol; 2021 Sep; 8(1):327-347. PubMed ID: 34255544
[TBL] [Abstract][Full Text] [Related]
22. Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle.
Torii S; Orba Y; Sasaki M; Tabata K; Wada Y; Carr M; Hobson-Peters J; Hall RA; Takada A; Fukuhara T; Matsuura Y; Hall WW; Sawa H
J Biol Chem; 2020 Jun; 295(23):7941-7957. PubMed ID: 32341071
[TBL] [Abstract][Full Text] [Related]
23. A Chikungunya Virus
Bartholomeeusen K; Utt A; Coppens S; Rausalu K; Vereecken K; Ariën KK; Merits A
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695432
[TBL] [Abstract][Full Text] [Related]
24. Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA.
Young AR; Locke MC; Cook LE; Hiller BE; Zhang R; Hedberg ML; Monte KJ; Veis DJ; Diamond MS; Lenschow DJ
PLoS Pathog; 2019 Aug; 15(8):e1007993. PubMed ID: 31465513
[TBL] [Abstract][Full Text] [Related]
25. Persistent Replication of a Chikungunya Virus Replicon in Human Cells Is Associated with Presence of Stable Cytoplasmic Granules Containing Nonstructural Protein 3.
Remenyi R; Gao Y; Hughes RE; Curd A; Zothner C; Peckham M; Merits A; Harris M
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875241
[TBL] [Abstract][Full Text] [Related]
26. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review.
Wang M; Wang L; Leng P; Guo J; Zhou H
Int J Biol Macromol; 2024 Mar; 262(Pt 2):129949. PubMed ID: 38311132
[TBL] [Abstract][Full Text] [Related]
27. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
[TBL] [Abstract][Full Text] [Related]
28. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of CHIKV-infected human fibroblast-like synoviocytes: Identification of host factors potentially associated with CHIKV replication and cellular pathogenesis.
Sukkaew A; Suksatu A; Roytrakul S; Smith DR; Ubol S
Microbiol Immunol; 2020 Jun; 64(6):445-457. PubMed ID: 32246487
[TBL] [Abstract][Full Text] [Related]
30. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
Bakhache W; Neyret A; Bernard E; Merits A; Briant L
J Virol; 2020 May; 94(10):. PubMed ID: 32132240
[TBL] [Abstract][Full Text] [Related]
31. Differential proteome analysis of chikungunya virus infection on host cells.
Thio CL; Yusof R; Abdul-Rahman PS; Karsani SA
PLoS One; 2013; 8(4):e61444. PubMed ID: 23593481
[TBL] [Abstract][Full Text] [Related]
32. Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo.
Rathore AP; Haystead T; Das PK; Merits A; Ng ML; Vasudevan SG
Antiviral Res; 2014 Mar; 103():7-16. PubMed ID: 24388965
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
34. Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.
Thaa B; Biasiotto R; Eng K; Neuvonen M; Götte B; Rheinemann L; Mutso M; Utt A; Varghese F; Balistreri G; Merits A; Ahola T; McInerney GM
J Virol; 2015 Nov; 89(22):11420-37. PubMed ID: 26339054
[TBL] [Abstract][Full Text] [Related]
35. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
36. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
37. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2019; 10():786. PubMed ID: 31031770
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of Alphaviruses to G3BP Deletion Correlates with Efficiency of Replicase Polyprotein Processing.
Götte B; Utt A; Fragkoudis R; Merits A; McInerney GM
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941782
[TBL] [Abstract][Full Text] [Related]
39. Mutation of CD2AP and SH3KBP1 Binding Motif in Alphavirus nsP3 Hypervariable Domain Results in Attenuated Virus.
Mutso M; Morro AM; Smedberg C; Kasvandik S; Aquilimeba M; Teppor M; Tarve L; Lulla A; Lulla V; Saul S; Thaa B; McInerney GM; Merits A; Varjak M
Viruses; 2018 Apr; 10(5):. PubMed ID: 29702546
[TBL] [Abstract][Full Text] [Related]
40. A New Host Factor Essential for Chikungunya Virus.
Schnierle BS
Trends Microbiol; 2020 Jan; 28(1):2-4. PubMed ID: 31780232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
